IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v11y2020i1d10.1038_s41467-020-19575-2.html
   My bibliography  Save this article

ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL

Author

Listed:
  • Silvia Pietrobono

    (Core Research Laboratory – Institute for Cancer Research and Prevention (ISPRO))

  • Giulia Anichini

    (Core Research Laboratory – Institute for Cancer Research and Prevention (ISPRO)
    University of Siena)

  • Cesare Sala

    (University of Florence)

  • Fabrizio Manetti

    (University of Siena)

  • Luciana L. Almada

    (Mayo Clinic)

  • Sara Pepe

    (Core Research Laboratory – Institute for Cancer Research and Prevention (ISPRO)
    University of Siena)

  • Ryan M. Carr

    (Mayo Clinic)

  • Brooke D. Paradise

    (Mayo Clinic)

  • Jann N. Sarkaria

    (Mayo Clinic)

  • Jaime I. Davila

    (Mayo Clinic, Rochester)

  • Lorenzo Tofani

    (University of Florence)

  • Ilaria Battisti

    (University of Padova and Azienda Ospedaliera di Padova)

  • Giorgio Arrigoni

    (University of Padova and Azienda Ospedaliera di Padova
    University of Padova)

  • Li Ying

    (Mayo Clinic)

  • Cheng Zhang

    (Mayo Clinic)

  • Hu Li

    (Mayo Clinic)

  • Alexander Meves

    (Mayo Clinic)

  • Martin E. Fernandez-Zapico

    (Mayo Clinic)

  • Barbara Stecca

    (Core Research Laboratory – Institute for Cancer Research and Prevention (ISPRO))

Abstract

Understanding the molecular events controlling melanoma progression is of paramount importance for the development of alternative treatment options for this devastating disease. Here we report a mechanism regulated by the oncogenic SOX2-GLI1 transcriptional complex driving melanoma invasion through the induction of the sialyltransferase ST3GAL1. Using in vitro and in vivo studies, we demonstrate that ST3GAL1 drives melanoma metastasis. Silencing of this enzyme suppresses melanoma invasion and significantly reduces the ability of aggressive melanoma cells to enter the blood stream, colonize distal organs, seed and survive in the metastatic environment. Analysis of glycosylated proteins reveals that the receptor tyrosine kinase AXL is a major effector of ST3GAL1 pro-invasive function. ST3GAL1 induces AXL dimerization and activation that, in turn, promotes melanoma invasion. Our data support a key role of the ST3GAL1-AXL axis as driver of melanoma metastasis, and highlight the therapeutic potential of targeting this axis to treat metastatic melanoma.

Suggested Citation

  • Silvia Pietrobono & Giulia Anichini & Cesare Sala & Fabrizio Manetti & Luciana L. Almada & Sara Pepe & Ryan M. Carr & Brooke D. Paradise & Jann N. Sarkaria & Jaime I. Davila & Lorenzo Tofani & Ilaria , 2020. "ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL," Nature Communications, Nature, vol. 11(1), pages 1-18, December.
    • Handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-19575-2
    DOI: 10.1038/s41467-020-19575-2
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-020-19575-2
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-020-19575-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-19575-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.